RNA-Loaded Dendritic Cell Cancer Vaccine
NCT00087984
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Cell Carcinoma
Interventions
BIOLOGICAL:
MB-002
Sponsor
Argos Therapeutics